These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


434 related items for PubMed ID: 7522004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
    [Abstract] [Full Text] [Related]

  • 3. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
    Bressler NM, Maguire MG, Murphy PL, Alexander J, Margherio R, Schachat AP, Fine SL, Stevens TS, Bressler SB.
    Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1220-31. PubMed ID: 1718250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251
    [Abstract] [Full Text] [Related]

  • 11. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Shiraga F, Ojima Y, Matsuo T, Takasu I, Matsuo N.
    Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of exudative age-related macular degeneration].
    Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):875-98. PubMed ID: 11193943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.